{"id":2301,"date":"2026-06-11T13:00:00","date_gmt":"2026-06-11T16:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2301"},"modified":"2026-06-11T13:00:00","modified_gmt":"2026-06-11T16:00:00","slug":"rss-clinica-medicina-psiquiatria-depressao-ansiedade-esquizofrenia-tdah-esketamina-rtms-psilocibina-ect","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/rss-clinica-medicina-psiquiatria-depressao-ansiedade-esquizofrenia-tdah-esketamina-rtms-psilocibina-ect\/","title":{"rendered":"RSS psiq: depress\u00e3o, esketamina, rTMS, psilocib"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente subaproveitada por gestores de cl\u00ednicas de psiquiatria que reduzem RSS a descarte de seringa e gaze<\/strong>. Em 2026, h\u00e1 um cen\u00e1rio desafiador \u2014 cl\u00ednicas de psiquiatria<\/strong> + TDM transtorno depressivo maior+ansiedade GAD+esquizofrenia+TB transtorno bipolar+TOC obsessivo-compulsivo+TDAH+autismo TEA+TPB borderline+dem\u00eancia+adic\u00e7\u00e3o<\/strong> + TRD treatment-resistant depression esketamina Spravato Janssen + intravenous ketamine + rTMS repetitive transcranial magnetic stimulation + ECT eletroconvulsoterapia + psilocibina Compass Pathways COMP360 fase 3<\/strong> + vortioxetina Brintellix+SSRIs sertralina+fluoxetina+paroxetina+SNRIs venlafaxina+duloxetina+desvenlafaxina+TCAs amitriptilina+nortriptilina+IMAOs+at\u00edpicos quetiapina+aripiprazol+olanzapina+lurasidona Latuda+brexpiprazol Rexulti+cariprazina Vraylar+lumateperona Caplyta<\/strong> + clozapina+esquizofrenia refrat\u00e1ria+xanomeline-trospium Cobenfy KarXT BMS muscar\u00ednico<\/strong> + l\u00edtio+valproato+lamotrigina+carbamazepina TB<\/strong> + TDAH metilfenidato Ritalina+lisdexanfetamina Venvanse+atomoxetina Strattera+viloxazina Qelbree<\/strong> geram fluxos heterog\u00eaneos de RSS Grupo A1 (sangue venoso l\u00edtio + tiroide TSH + fun\u00e7\u00e3o renal+hep\u00e1tica + ECG+QTc) + Grupo A2 (escarro+secre\u00e7\u00e3o raro) + Grupo B (psicotr\u00f3pico SSRI+SNRI+TCA+IMAO+at\u00edpico+l\u00edtio+benzo+anticonvulsivante+estimulante+ESQ refrat\u00e1ria clozapina+xanomeline-trospium Lista B\/C5+Portaria 344 controlado) + Grupo E (perfuro pen+seringa+agulha+IV ketamine+esketamina nasal+ECT eletrodos+rTMS bobina).<\/p>\n

Para o gestor que opera ou planeja cl\u00ednica de psiquiatria, \u00e9 fundamental dimensionar RSS espec\u00edfico desde o in\u00edcio.<\/p>\n

Os 5 fluxos psiqui\u00e1tricos<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, o RSS psiq tem 5 fluxos.<\/p>\n\n\n\n\n\n\n\n\n\n
Fluxo<\/th>\nVolume<\/th>\nFrequ\u00eancia<\/th>\nParticularidade<\/th>\n<\/tr>\n<\/thead>\n
TDM+ansiedade SSRI<\/td>\n4-12 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nSertralina+fluox+SNRI<\/td>\n<\/tr>\n
TRD esket+rTMS+ECT<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nSpravato+ketamine IV<\/td>\n<\/tr>\n
Esquizofrenia+TB<\/td>\n3-9 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nAt\u00edpicos+clozapina+l\u00edtio<\/td>\n<\/tr>\n
TDAH+TOC+TPB+autismo<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nEstimulante+SSRI+TPB DBT<\/td>\n<\/tr>\n
Adic\u00e7\u00e3o+dem\u00eancia+geri<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nNaltrexona+lecanemab<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 13-39 kg\/dia<\/strong> em cl\u00ednica psiq m\u00e9dia porte.<\/p>\n

TDM + ansiedade + SSRIs + SNRIs + at\u00edpicos modernos: o est\u00e1gio comum<\/h2>\n

A primeira camada \u00e9 TDM+ansiedade. Padr\u00e3o setorial inclui (a) TDM transtorno depressivo maior<\/strong> com DSM-5-TR crit\u00e9rios + PHQ-9+HAM-D+MADRS escalas + Hamilton + sertralina Zoloft+fluoxetina Prozac+paroxetina Aropax+escitalopram Lexapro+citalopram Celexa SSRIs 1L; (b) SNRIs serotonin-norepinephrine<\/strong> com venlafaxina Effexor + duloxetina Cymbalta + desvenlafaxina Pristiq + levomilnaciprano Fetzima + 2L; (c) vortioxetina Brintellix Lundbeck Takeda<\/strong> multimodal + agomelatina Valdoxan + bupropiona Wellbutrin at\u00edpico + mirtazapina Remeron tetrac\u00edclico + tianeptina + trazodona; (d) ansiedade GAD generalized anxiety disorder<\/strong> com SSRI+SNRI 1L + buspirona BuSpar + benzo curto-prazo crisis + pregabalina+gabapentina + propranolol situacional + hidroxizina; (e) escalas+rating<\/strong> com PHQ-9 0-27 + GAD-7 0-21 + HAM-D 0-52 + MADRS 0-60 + BDI-II Beck+Hamilton anxiety HAM-A + CGI Clinical Global Impressions + SDS Sheehan disability + Q-LES-Q quality life enjoyment.<\/p>\n

Cl\u00ednica com TDM+ansiedade madura escala remiss\u00e3o MADRS<10 50-65% 8 semanas<\/strong> + escala vortioxetina cogni\u00e7\u00e3o superior SSRI<\/strong> + otimiza titula\u00e7\u00e3o SSRI\/SNRI tolerabilidade<\/strong>. Como discutimos no post sobre psiq pedi\u00e1trica indireto<\/a>, TDM \u00e9 base.<\/p>\n

TRD esketamina Spravato + IV ketamine + rTMS + ECT + psilocibina COMP360: o est\u00e1gio refrat\u00e1rio<\/h2>\n

A segunda camada \u00e9 TRD. Padr\u00e3o setorial inclui (a) TRD treatment-resistant depression<\/strong> com falha 2+ antidepressivos doses adequadas + Maudsley Treatment Resistance Staging + STAR*D + esketamina Spravato Janssen intranasal 28-84mg + IV ketamine off-label 0,5 mg\/kg infusion 40min; (b) rTMS repetitive transcranial magnetic stimulation<\/strong> com NeuroStar Neuronetics + MagVenture MagVita + Brainsway Deep TMS + dorsolateral prefrontal cortex DLPFC esquerdo + 10Hz 3000 pulsos \u00d7 30 sess\u00f5es + Stanford SAINT 5-day intensive remission 79%; (c) ECT eletroconvulsoterapia<\/strong> com bilateral+unilateral right + Thymatron + MECTA + ASA anestesia geral + propofol+succinilcolina + monitor EEG + 6-12 sess\u00f5es 2-3\u00d7 semana + remiss\u00e3o TRD 60-80%; (d) psilocibina Compass Pathways COMP360<\/strong> fase 3 + Usona Institute + MAPS MDMA-assisted therapy PTSD aprova\u00e7\u00e3o FDA pendente + ketamina assistida + LSD+ibogaina pesquisa; (e) vagal nerve stimulation VNS<\/strong> LivaNova VNS Therapy + DBS deep brain stimulation Medtronic + alternativa intervencional + neurofeedback + biofeedback + transcranial direct current stimulation tDCS Soterix Medical.<\/p>\n

Cl\u00ednica com TRD esket+rTMS+ECT madura escala esketamina Spravato remiss\u00e3o TRD 49% 4 semanas<\/strong> + escala SAINT Stanford 5-day remiss\u00e3o 79%<\/strong> + escala ECT remiss\u00e3o 60-80% TRD<\/strong>. Conex\u00e3o com Lista C5<\/a>.<\/p>\n

Esquizofrenia + TB + TOC + TDAH + esquizofrenia refrat\u00e1ria xanomeline-trospium Cobenfy: o est\u00e1gio cr\u00f4nico+resistente<\/h2>\n

A terceira camada \u00e9 ESQ+TB+TOC+TDAH. Padr\u00e3o setorial inclui (a) esquizofrenia tratamento<\/strong> com at\u00edpicos olanzapina Zyprexa+quetiapina Seroquel+aripiprazol Abilify+risperidona Risperdal+paliperidona Invega+lurasidona Latuda+brexpiprazol Rexulti+cariprazina Vraylar+lumateperona Caplyta+ziprasidona+iloperidona+asenapina+pimavanserin Nuplazid; (b) esquizofrenia refrat\u00e1ria<\/strong> com clozapina Clozaril gold standard 2L+ + monitoramento agranulocitose semanal hemograma + xanomeline-trospium Cobenfy KarXT BMS muscar\u00ednico M1\/M4 agonista FDA 2024 first-in-class + LAIs long-acting injectables Risperdal Consta+Invega Sustenna+Trinza+Hafyera+Aristada+Abilify Maintena; (c) TB transtorno bipolar<\/strong> com l\u00edtio Carbolitium+valproato Depakene+lamotrigina Lamictal+carbamazepina Tegretol+oxcarbazepina+at\u00edpicos+combina\u00e7\u00e3o + TB tipo I+II+ciclot\u00edmico+misto+rapid cycler; (d) TOC obsessivo-compulsivo<\/strong> com SSRI altas doses + clomipramina Anafranil + ERP exposure response prevention TCC + fluvoxamina Luvox + esquizo refrat\u00e1ria+TOC refrat\u00e1ria DBS deep brain stimulation; (e) TDAH<\/strong> com metilfenidato Ritalina LA+Concerta+Ritalin OROS+lisdexanfetamina Venvanse+atomoxetina Strattera+viloxazina Qelbree non-stimulant + clonidina+guanfacina alpha-2 agonista + comportamental Russell Barkley.<\/p>\n

Cl\u00ednica com ESQ+TB+TOC+TDAH madura escala remiss\u00e3o clozapina TRS 30-60%<\/strong> + escala xanomeline-trospium Cobenfy first-in-class muscar\u00ednico<\/strong> + escala TDAH metilfenidato resposta 70-80%<\/strong>. Conex\u00e3o com pediatria DM1+endo<\/a>.<\/p>\n

Tr\u00eas perfis de RSS por capacidade psiq<\/h2>\n

Cl\u00ednica psiq b\u00e1sica.<\/strong> 2 fluxos. Custo mensal R$ 12.000-32.000<\/strong> mas perda de TRD esketamina+rTMS+ECT+clozapina.<\/p>\n

Cl\u00ednica psiq m\u00e9dia.<\/strong> 3 fluxos. Custo mensal R$ 24.000-58.000<\/strong>, captura TDM+ansiedade+ESQ.<\/p>\n

Cl\u00ednica psiq completa 5 fluxos.<\/strong> TDM+TRD+ESQ+TB+TOC+TDAH + integra\u00e7\u00e3o com servi\u00e7os hospitalares<\/a>. Custo mensal R$ 45.000-105.000<\/strong>, efic\u00e1cia 95%, ROI 800-2.500% via captura psiqui\u00e1trica + esketamina Spravato + rTMS Stanford SAINT + Cobenfy KarXT first-in-class.<\/p>\n

Os tr\u00eas erros que aparecem em psiq<\/h2>\n

O primeiro \u00e9 a subdimensionamento Lista B\/C5 psicotr\u00f3pico+esketamina+clozapina<\/strong>. Sem segrega\u00e7\u00e3o SSRI+SNRI+TCA+IMAO+at\u00edpico+l\u00edtio+benzo+esketamina Spravato+ketamina IV+clozapina+xanomeline-trospium Cobenfy + Portaria 344 controlado + Lista B\/C5 = n\u00e3o-conformidade ANVISA RDC 222 + risco contamina\u00e7\u00e3o cruzada profissional + impacto financeiro.<\/p>\n

O segundo \u00e9 a mistura TDM + ansiedade + ESQ + TB + TOC + TDAH<\/strong>. Confunde rastreabilidade etiol\u00f3gica + impossibilita escalas DSM-5-TR+PHQ-9+HAM-D+MADRS+CGI+Maudsley TRS + risco indica\u00e7\u00e3o inadequada (SSRI vs antipsic\u00f3tico vs l\u00edtio vs estimulante).<\/p>\n

O terceiro \u00e9 a falta de protocolo monitoramento clozapina hemograma semanal<\/strong>. Sem REMS Risk Evaluation Mitigation Strategy + monitoramento agranulocitose + neutr\u00f3filos seriados = risco mortalidade agranulocitose 0,8% + zero rastreabilidade seguran\u00e7a.<\/p>\n

A regula\u00e7\u00e3o de RSS psiq no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com psiquiatria especializada como prioridade. As institui\u00e7\u00f5es que estruturam fluxos completos desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A ABP Associa\u00e7\u00e3o Brasileira Psiquiatria<\/a> \u00e9 refer\u00eancia t\u00e9cnica nacional.<\/p>\n

Solicite cota\u00e7\u00e3o RSS psiq 5 fluxos completos<\/a><\/strong> \u2014 cap\u00edtulo dedicado a TDM DSM-5-TR+PHQ-9+HAM-D+MADRS+SSRIs sertralina Zoloft+fluoxetina Prozac+paroxetina Aropax+escitalopram Lexapro+citalopram+SNRIs venlafaxina Effexor+duloxetina Cymbalta+desvenlafaxina Pristiq+levomilnaciprano+vortioxetina Brintellix Lundbeck Takeda multimodal+agomelatina Valdoxan+bupropiona Wellbutrin+mirtazapina Remeron+trazodona+ansiedade GAD-7+buspirona+benzo+pregabalina+gabapentina, TRD Spravato esketamina Janssen intranasal+IV ketamine 0,5 mg\/kg+rTMS NeuroStar Neuronetics+MagVenture+Brainsway Deep TMS+DLPFC+Stanford SAINT 5-day 79%+ECT bilateral+unilateral right+Thymatron+MECTA+propofol+succinilcolina+psilocibina Compass Pathways COMP360 fase 3+Usona+MAPS MDMA-assisted PTSD+VNS LivaNova+DBS Medtronic+tDCS Soterix Lista C5, esquizofrenia at\u00edpicos olanzapina Zyprexa+quetiapina Seroquel+aripiprazol Abilify+risperidona+paliperidona+lurasidona Latuda+brexpiprazol Rexulti+cariprazina Vraylar+lumateperona Caplyta+pimavanserin Nuplazid+clozapina Clozaril gold standard 2L+xanomeline-trospium Cobenfy KarXT BMS muscar\u00ednico M1\/M4 FDA 2024 first-in-class+LAIs Risperdal Consta+Invega Sustenna+Trinza+Hafyera+Aristada+Abilify Maintena+TB l\u00edtio Carbolitium+valproato+lamotrigina+carbamazepina+TOC SSRI altas doses+clomipramina Anafranil+ERP TCC+TDAH metilfenidato Ritalina+Concerta+lisdexanfetamina Venvanse+atomoxetina Strattera+viloxazina Qelbree+clonidina+guanfacina+Russell Barkley comportamental.<\/p>\n","protected":false},"excerpt":{"rendered":"

RSS psiquiatria: depress\u00e3o + esketamina + rTMS + psilocibina + ECT. Veja.<\/p>\n","protected":false},"author":3,"featured_media":2300,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[2298,3140,831,3139],"class_list":["post-2301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-esketamina","tag-psilocibina","tag-psiquiatria","tag-rtms"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2301"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2301\/revisions"}],"predecessor-version":[{"id":4373,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2301\/revisions\/4373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2300"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}